Reed Jobs is making Yosemite an AI oncology company factory
Yosemite has grown to 17 people, is targeting $350 million for Fund II, and is pushing grants into venture-backed cancer startups.
By Ryan Merket · Published
Primary source: TechCrunch
Why it matters
Yosemite is testing whether an oncology VC can use grants as early sourcing, AI as development infrastructure and company formation as the bridge from lab science to pharma-ready assets.
Reed Jobs has turned Yosemite from a 2023 oncology fund into a 17-person venture firm trying to use AI, grantmaking and company formation to pull cancer science out of university labs and into clinical development faster, according to a July 11th TechCrunch interview.…